Research shows that Danlou tablet, a traditional Chinese herbal medicine, helped obese mice lose weight and improve their blood sugar control by changing their gut bacteria and how their livers process fat. According to Gram Research analysis of this 2026 study, treated mice showed reduced body weight, improved insulin sensitivity, and healthier livers compared to untreated obese mice. However, this is an animal study, and human clinical trials are needed before this treatment could be recommended for people with obesity or type 2 diabetes.
Researchers tested a traditional Chinese medicine called Danlou tablet on obese mice to see if it could help them lose weight and improve their blood sugar control. According to Gram Research analysis, the treatment worked by changing the bacteria in the mice’s guts and how their livers process fat. The mice that received the medicine lost weight, had better insulin sensitivity, and showed less liver damage compared to mice that didn’t receive treatment. These findings suggest the medicine might one day help people with obesity and type 2 diabetes, though human studies are still needed to confirm these results.
Key Statistics
A 2026 research study in Frontiers in Microbiology found that mice treated with Danlou tablet showed improved insulin sensitivity and reduced liver fat accumulation compared to untreated obese mice fed a high-fat diet for 22 weeks.
According to research reviewed by Gram, Danlou tablet treatment restored the balance of gut bacteria in obese mice, specifically correcting the Firmicutes/Bacteroidota ratio and increasing overall bacterial diversity.
The study demonstrated that Danlou tablet’s therapeutic benefits were associated with enhanced fatty acid metabolism in the liver, with treated mice showing improved ability to break down fats through beta-oxidation.
Research shows that Danlou tablet reduced body weight, adiposity, dyslipidemia, and hepatic steatosis in high-fat diet-fed mice while also suppressing inflammatory pathways in the liver.
The Quick Take
- What they studied: Whether a traditional Chinese herbal medicine called Danlou tablet could help mice lose weight and improve their ability to control blood sugar when they were fed a high-fat diet.
- Who participated: Laboratory mice (C57BL/6N strain) that were fed a high-fat diet for 22 weeks to make them obese. Some mice received the herbal medicine while others did not.
- Key finding: Mice treated with Danlou tablet lost weight, had less body fat, better blood sugar control, and healthier livers compared to untreated mice. The medicine appeared to work by changing the types of bacteria in their digestive systems.
- What it means for you: This research suggests a traditional Chinese medicine might help people with obesity and type 2 diabetes, but these are early-stage animal studies. Human clinical trials would be needed before doctors could recommend this treatment. If you have obesity or diabetes, talk to your doctor about proven treatment options.
The Research Details
Scientists conducted a controlled experiment using laboratory mice to test whether Danlou tablet could reverse the harmful effects of eating a high-fat diet. For 22 weeks, mice were fed either a regular diet or a high-fat diet. Some of the mice on the high-fat diet also received Danlou tablet treatment, while others did not. This setup allowed researchers to compare three groups: healthy mice, obese mice without treatment, and obese mice with treatment.
The researchers measured many different things to understand how the medicine worked. They tracked body weight and fat levels, tested how well the mice’s bodies handled blood sugar, checked blood chemistry, and examined liver tissue under a microscope. They also analyzed the bacteria living in the mice’s digestive systems using genetic sequencing, measured hundreds of different molecules in the blood using advanced chemistry techniques, and studied which genes were active in the liver.
This multi-layered approach allowed researchers to see not just whether the medicine worked, but also how it worked at different levels—from changing gut bacteria to affecting how the liver processes fat.
This research approach is important because obesity and related diseases like type 2 diabetes are major health problems worldwide. Traditional Chinese medicines have been used for thousands of years, but scientists need to understand exactly how they work using modern scientific methods. By studying multiple biological systems at once (gut bacteria, blood chemistry, liver function, and gene activity), researchers can identify the actual mechanisms behind the medicine’s effects. This comprehensive approach makes the findings more convincing and helps determine whether the treatment might work in humans.
This study was published in Frontiers in Microbiology, a peer-reviewed scientific journal, which means other experts reviewed the work before publication. The researchers used standardized laboratory mice and controlled conditions, which makes the results more reliable. However, this is a preclinical animal study, meaning it was done in mice, not humans. Animal studies don’t always translate to human results, so these findings need to be confirmed in human clinical trials before the medicine can be recommended for patients. The study did not specify the exact number of mice used in each group, which would have been helpful for evaluating the strength of the results.
What the Results Show
Mice treated with Danlou tablet showed significant improvements across multiple measures of health. They gained less weight than untreated obese mice and had less body fat. Their blood sugar control improved, meaning their bodies handled glucose better and they showed signs of improved insulin sensitivity—the ability of cells to respond to insulin and take up glucose from the blood.
The liver, which is often damaged in obesity, showed remarkable improvement in treated mice. Liver tissue had less fat accumulation (a condition called fatty liver disease), less inflammation, and less oxidative stress (cellular damage from harmful molecules). These improvements are important because fatty liver disease is a common complication of obesity that can lead to serious liver damage.
At the microscopic level, the medicine changed the composition of bacteria living in the mice’s digestive systems. Specifically, it restored the balance between two major types of bacteria (Firmicutes and Bacteroidota), which are often imbalanced in obese individuals. The medicine also increased overall bacterial diversity, which is generally associated with better health.
Beyond the main results, researchers discovered that the medicine’s benefits were connected to improved fat metabolism. The mice’s bodies showed better ability to break down fatty acids through a process called beta-oxidation, which is how cells convert fat into energy. In the liver, genes related to processing and eliminating fats were more active in treated mice. Additionally, the liver showed enhanced antioxidant defense, meaning better protection against cellular damage. The research also revealed that the medicine affected genes involved in processing foreign substances (xenobiotic metabolism), which is important for the liver’s detoxification functions.
This study builds on existing knowledge that Danlou tablet helps with heart disease by improving lipid (fat) metabolism. Previous research suggested the medicine might help with obesity-related problems, but this is the first comprehensive study showing exactly how it works. The findings align with growing scientific understanding that gut bacteria play a crucial role in obesity and metabolic disease. The study confirms what other research has shown: that restoring healthy gut bacteria and improving liver function are important for treating obesity and insulin resistance. However, most previous obesity research has focused on single mechanisms, while this study’s multi-system approach provides a more complete picture.
This study has several important limitations. First, it was conducted in mice, not humans, so the results may not directly apply to people. Mice and humans have different digestive systems, metabolism, and genetics. Second, the study did not specify how many mice were used in each group, making it difficult to assess the statistical strength of the findings. Third, the research was relatively short-term (22 weeks), so we don’t know if the benefits would continue long-term or if side effects might develop. Fourth, the study didn’t compare Danlou tablet to other obesity treatments or medications, so we can’t say whether it’s better or worse than existing options. Finally, this is a preclinical study, meaning human clinical trials are needed before this medicine could be recommended for patients.
The Bottom Line
Based on this research, Danlou tablet shows promise as a potential treatment for obesity and type 2 diabetes, but it is not yet ready for human use outside of clinical trials. The evidence is strong in mice (high confidence for animal model), but human studies are needed before any recommendations can be made. If you have obesity or type 2 diabetes, continue working with your doctor on proven treatments like diet changes, exercise, and medications that have been tested in humans. Do not self-treat with Danlou tablet or other herbal medicines without medical supervision, as they may interact with other medications or have unexpected effects.
This research is most relevant to: (1) People with obesity or type 2 diabetes who are interested in traditional medicine approaches; (2) Researchers studying how gut bacteria affect metabolism; (3) Pharmaceutical companies developing new obesity treatments; (4) Doctors looking for new therapeutic options to offer patients. This research should NOT be used by people to self-treat obesity or diabetes without medical supervision. People with liver disease, those taking blood-thinning medications, or pregnant women should be especially cautious about herbal treatments and should consult their doctor.
In mice, the benefits appeared over the 22-week study period. If this medicine were to be tested in humans, it would likely take several years of clinical trials to determine the appropriate dose, how long treatment should continue, and whether benefits appear within weeks or months. Realistic expectations would be that any human treatment would require at least 8-12 weeks to show measurable effects, similar to other obesity medications. Long-term studies would be needed to determine if benefits persist and whether the treatment is safe for years of use.
Frequently Asked Questions
Can I take Danlou tablet to help with my weight loss or diabetes?
Not yet based on human evidence. This research was conducted in mice, not people. While results are promising, human clinical trials are needed before doctors can recommend Danlou tablet for weight loss or diabetes. Talk to your doctor about proven treatments that have been tested in humans.
How does Danlou tablet help with obesity according to this research?
The study found that Danlou tablet works through multiple mechanisms: it changes the types of bacteria in the digestive system, improves how the liver breaks down fat, reduces liver inflammation, and enhances the body’s ability to handle blood sugar. These changes work together to reduce weight and improve metabolic health.
Is this research applicable to humans or just mice?
This research was conducted only in mice. While the findings are interesting and suggest potential benefits, animal studies don’t always translate to humans. Researchers would need to conduct human clinical trials to determine if Danlou tablet is safe and effective for people with obesity or type 2 diabetes.
What role do gut bacteria play in obesity according to this study?
The research shows that obese mice had imbalanced gut bacteria, and Danlou tablet restored this balance by increasing bacterial diversity and correcting the ratio of different bacterial types. These changes in gut bacteria were closely linked to improvements in liver function and fat metabolism.
Are there any side effects or risks mentioned in this research?
This animal study did not report any adverse effects in the treated mice. However, because this is preclinical research, potential side effects in humans remain unknown. Any herbal medicine should only be used under medical supervision, as it could interact with other medications or cause unexpected effects.
Want to Apply This Research?
- If a user is interested in this research area, they could track: (1) Body weight weekly; (2) Waist circumference monthly; (3) Energy levels and digestion quality daily using a simple 1-10 scale; (4) Blood sugar readings if they have diabetes; (5) Liver function tests if recommended by their doctor. These measurements would help users monitor their own metabolic health while working with their healthcare provider.
- Users could implement evidence-based behaviors supported by this research: (1) Eat more fiber-rich foods to support healthy gut bacteria; (2) Reduce high-fat processed foods; (3) Increase physical activity to improve insulin sensitivity; (4) Track digestive health and energy levels; (5) Log any herbal supplements with their doctor’s knowledge. The app could provide reminders for these behaviors and show how they correlate with health metrics over time.
- Set up monthly check-ins to review trends in weight, energy, digestion, and blood sugar (if applicable). Create a dashboard showing the connection between dietary choices and health markers. If the user is working with a healthcare provider on obesity or diabetes management, share monthly reports with their doctor. Track adherence to lifestyle changes and celebrate milestones. Use the app to maintain a food and supplement log to identify patterns and potential interactions.
This research was conducted in laboratory mice and has not been tested in humans. Danlou tablet is not approved by the FDA for treating obesity or diabetes in the United States. Do not use this herbal medicine to self-treat obesity, diabetes, or any other medical condition without consulting your healthcare provider. Herbal supplements can interact with medications, may not be safe for all people, and their quality and purity are not regulated like pharmaceutical drugs. Always discuss any herbal treatments with your doctor before starting them. If you have obesity or type 2 diabetes, work with your healthcare provider to develop a treatment plan based on proven, evidence-based therapies that have been tested in humans.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.